| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.066 | 0.04 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.04 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.04 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.11 | 0.04 |